Benzinga | Jun 9, 2021 04:58PM EDT

Spero Therapeutics ClincialTrials.gov Study Record Detail 'Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis'

https://clinicaltrials.gov/ct2/show/NCT04919954